Page last updated: 2024-11-05

2-hydroxy-1-naphthaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-hydroxy-1-naphthaldehyde, also known as 1-hydroxy-2-naphthaldehyde, is a versatile organic compound with a range of applications in various fields. It serves as a precursor for the synthesis of several important organic compounds, including dyes, pharmaceuticals, and pesticides. Its chelating properties have been explored in the development of metal-organic frameworks (MOFs) and coordination polymers. 2-hydroxy-1-naphthaldehyde exhibits fluorescence properties and has been investigated for its potential as a fluorescent probe for metal ion sensing. Its biological activities, such as antioxidant, antimicrobial, and anticancer properties, have also been studied. The compound's unique structural features, including its aromatic ring system and hydroxyl group, contribute to its diverse properties and make it a subject of ongoing research.'

2-hydroxynaphthaldehyde: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-hydroxy-1-naphthaldehyde : A member of the class of naphthaldehydes that is naphthalene-1-carbaldehyde substituted by a hydroxy group at position 2. Active core of sirtinol (CHEBI:73158). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12819
CHEMBL ID3265255
CHEBI ID137369
SCHEMBL ID304032
MeSH IDM0172361

Synonyms (73)

Synonym
pp9cfn7qnl ,
unii-pp9cfn7qnl
4-08-00-01160 (beilstein handbook reference)
ec 211-902-0
BB 0243290
2-hydroxy-naphthalene-1-carbaldehyde
708-06-5
2-hydroxy-1-naphthylaldehyde
2-hydroxy-1-naphthalenecarboxaldehyde
1-naphthalenecarboxaldehyde, 2-hydroxy-
2-hydroxy-.alpha.-naphthaldehyde
nsc2104
2-hydroxy-1-naphthaldehyde
1-naphthaldehyde, 2-hydroxy-
1-formyl-2-naphthol
nsc-2104
2-naphthol 1-carboxaldehyde
.beta.-hydroxy-.alpha.-naphthaldehyde
1-hydroxy-2-naphthalenecarboxaldehyde
2-hydroxynaphthaldehyde
2-hydroxy-1-naphthalaldehyde
2-hydroxy-1-napthaldehyde
nsc 2104
brn 0742777
einecs 211-902-0
ai3-24517
beta-hydroxynaphthaldehyde
AH-034/32464020
nsc-402586
inchi=1/c11h8o2/c12-7-10-9-4-2-1-3-8(9)5-6-11(10)13/h1-7,13
2-hydroxy-1-naphthaldehyde, technical grade
PROBES2_000080
STK189371
2-hydroxynaphthalene-1-carbaldehyde
CHEBI:137369
AC-5786
AKOS000118889
2-naphthol-1-aldehyde
H0275
bdbm50013794
chembl3265255 ,
A23776
A18872
2-hydroxy-naphthaldehyde
101482-89-7
FT-0612522
2-hydroxynaphthalene-1-carboxaldehyde
SCHEMBL304032
2-hydroxy-1-naphthoaldehyde
2-hydroxy-naphthalene 1-carbaldehyde
2-hydroxynaphthalene-1-aldehyde
DTXSID9061041
1-formyl-2-hydroxy-naphthalene
2-hydroxy-1-naphthalenealdehyde
.beta.-hydroxynaphthaldehyde
Q-200286
CS-W017605
cfl-137
mfcd00004005
F0020-1892
D77812
1-naphthalenecarboxaldehyde, 2-hydroxy
(z)-1-(hydroxymethylene)naphthalen-2(1h)-one
AS-14481
8-naphthol-1-carbonyl chloride
nc-014
Q63398130
AMY40301
beta-hydroxy-alpha-naphthaldehyde
EN300-18408
HY-W016889
Z57772483
PD139178

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Zinc neurotoxicity has been demonstrated in ischemic, seizure, hypoglycemic, and trauma-induced neuronal death where Zn(2+) is thought to be synaptically released and taken up in neighbouring neurons, reaching toxic concentrations."( Zinc neurotoxicity is dependent on intracellular NAD levels and the sirtuin pathway.
Cai, AL; Sheline, CT; Zipfel, GJ, 2006
)
0.33

Dosage Studied

ExcerptRelevanceReference
" The procedure was successfully applied to the assay of the pure amino acids in a mixture and their pharmaceutical dosage forms."( High-performance liquid chromatographic determination of some amino acids after derivatization with 2-hydroxy-1-naphthaldehyde.
al-Ghannam, SM; el-Brashy, AM, 1997
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
naphthaldehydesAn arenecarbaldehyde that is a mono or poly-substituted naphthalene in which at least one of the substituents is a formyl group.
naphtholsAny hydroxynaphthalene derivative that has a single hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Serine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)IC50 (µMol)9.73200.04532.28609.9390AID1140864
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (20)

Processvia Protein(s)Taxonomy
endothelial cell proliferationSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
mRNA catabolic processSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
protein phosphorylationSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
regulation of macroautophagySerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
positive regulation of RNA splicingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
cellular response to unfolded proteinSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
response to endoplasmic reticulum stressSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulusSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
peptidyl-serine autophosphorylationSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
IRE1-mediated unfolded protein responseSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
positive regulation of JUN kinase activitySerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
protein autophosphorylationSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
mRNA splicing, via endonucleolytic cleavage and ligationSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
cellular response to hydrogen peroxideSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
cellular response to glucose stimulusSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
positive regulation of endoplasmic reticulum unfolded protein responseSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
insulin metabolic processSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferationSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
peptidyl-serine trans-autophosphorylationSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (14)

Processvia Protein(s)Taxonomy
magnesium ion bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
RNA endonuclease activitySerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
platelet-derived growth factor receptor bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
protein bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
ATP bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
enzyme bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
Hsp70 protein bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
identical protein bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
protein homodimerization activitySerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
ADP bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
Hsp90 protein bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
unfolded protein bindingSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (9)

Processvia Protein(s)Taxonomy
nuclear inner membraneSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
mitochondrionSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
endoplasmic reticulumSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
endoplasmic reticulum membraneSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
Ire1 complexSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
AIP1-IRE1 complexSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
IRE1-TRAF2-ASK1 complexSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
IRE1-RACK1-PP2A complexSerine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1140864Inhibition of human recombinant puritin-His-tagged IRE-1 RNase expressed in SF21 cells using XBP-1 RNA stem loop as substrate incubated for 30 mins prior to substrate addition measured after 2 hrs by FRET-suppression assay2014Journal of medicinal chemistry, May-22, Volume: 57, Issue:10
Synthesis of novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (41)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.44)18.7374
1990's6 (14.63)18.2507
2000's12 (29.27)29.6817
2010's20 (48.78)24.3611
2020's2 (4.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.56 (24.57)
Research Supply Index3.74 (2.92)
Research Growth Index5.29 (4.65)
Search Engine Demand Index53.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other41 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]